BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34998195)

  • 1. Tumor acidity-activatable photothermal/Fenton nanoagent for synergistic therapy.
    Yang Z; Zhang L; Wei J; Li R; Xu Q; Hu H; Xu Z; Ren J; Wong CY
    J Colloid Interface Sci; 2022 Apr; 612():355-366. PubMed ID: 34998195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polypyrrole-based nanotheranostic agent for MRI guided photothermal-chemodynamic synergistic cancer therapy.
    Zhou B; Yin C; Feng Q; Wu Y; Pan X; Liu C; Tian J; Geng S; Wang K; Xing J; Cao Y; Shou P; Yu Z; Wu A
    Nanoscale; 2021 Nov; 13(45):19085-19097. PubMed ID: 34761764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper-based theranostic nanocatalysts for synergetic photothermal-chemodynamic therapy.
    Zuo W; Fan Z; Chen L; Liu J; Wan Z; Xiao Z; Chen W; Wu L; Chen D; Zhu X
    Acta Biomater; 2022 Jul; 147():258-269. PubMed ID: 35605954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clearable Theranostic Platform with a pH-Independent Chemodynamic Therapy Enhancement Strategy for Synergetic Photothermal Tumor Therapy.
    Chen Q; Luo Y; Du W; Liu Z; Zhang S; Yang J; Yao H; Liu T; Ma M; Chen H
    ACS Appl Mater Interfaces; 2019 May; 11(20):18133-18144. PubMed ID: 31046230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. All-in-one CoFe
    Chen N; Wang Y; Zeng Y; Li Y; Pan Z; Li H; Chen J; Chen Z; Yuan J; Yan W; Lu YJ; Liu X; He Y; Zhang K
    Biomater Sci; 2023 Jan; 11(3):828-839. PubMed ID: 36453535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photothermal nanozymes to self-augment combination cancer therapy by dual-glutathione depletion and hyperthermia/acidity-activated hydroxyl radical generation.
    Wang TH; Shen MY; Yeh NT; Chen YH; Hsu TC; Chin HY; Wu YT; Tzang BS; Chiang WH
    J Colloid Interface Sci; 2023 Nov; 650(Pt B):1698-1714. PubMed ID: 37499626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manganese-containing polydopamine nanoparticles as theranostic agents for magnetic resonance imaging and photothermal/chemodynamic combined ferroptosis therapy treating gastric cancer.
    Chen Z; Li Z; Li C; Huang H; Ren Y; Li Z; Hu Y; Guo W
    Drug Deliv; 2022 Dec; 29(1):1201-1211. PubMed ID: 35403518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose/Glutathione Co-triggered Tumor Hypoxia Relief and Chemodynamic Therapy to Enhance Photothermal Therapy in Bladder Cancer.
    Chen WH; Yu KJ; Jhou JW; Pang HH; Weng WH; Lin WS; Yang HW
    ACS Appl Bio Mater; 2021 Oct; 4(10):7485-7496. PubMed ID: 35006706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fe
    Wu H; Cheng K; He Y; Li Z; Su H; Zhang X; Sun Y; Shi W; Ge D
    ACS Biomater Sci Eng; 2019 Feb; 5(2):1045-1056. PubMed ID: 33405795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ellagic acid-Fe@BSA nanoparticles for endogenous H
    Tian Q; An L; Tian Q; Lin J; Yang S
    Theranostics; 2020; 10(9):4101-4115. PubMed ID: 32226542
    [No Abstract]   [Full Text] [Related]  

  • 11. In-Situ-Bloomed Micrometer-Scale Ultrathin Nanosheets in Tumor-Microenvironment for Intensive Photothermal-Enhanced Chemodynamic Therapy.
    Yang L; Zhu XJ; Qu M; Xu TR; Ye YM; Zeng ZZ; Zhang J; Wang LK; Yu ZP; Zhou HP
    ACS Appl Bio Mater; 2021 May; 4(5):4507-4521. PubMed ID: 35006787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGCG-vanadium nanomedicine with neutral pH Fenton reaction activity inhibits heat shock proteins for enhanced photothermal/chemodynamic therapy.
    Wang R; Cao HC; Yang Q; Wei S; Liu T; Shi H
    Int J Biol Macromol; 2024 Jun; 271(Pt 2):132481. PubMed ID: 38763233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NIR-II-driven and glutathione depletion-enhanced hypoxia-irrelevant free radical nanogenerator for combined cancer therapy.
    Zhang L; Fan Y; Yang Z; Yang M; Wong CY
    J Nanobiotechnology; 2021 Sep; 19(1):265. PubMed ID: 34488803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of Fe
    Luo K; Zhao J; Jia C; Chen Y; Zhang Z; Zhang J; Huang M; Wang S
    ACS Appl Mater Interfaces; 2020 May; 12(20):22650-22660. PubMed ID: 32330380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harnessing inorganic nanomaterials for chemodynamic cancer therapy.
    Mohammed DF; Madlool HA; Faris M; Shalan BH; Hasan HH; Azeez NF; Abbas FH
    Nanomedicine (Lond); 2022 Oct; 17(24):1891-1906. PubMed ID: 36647807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron oxide-EDTA nanoparticles for chelation-enhanced chemodynamic therapy and ion interference therapy.
    Chen C; Meng Q; Liu Z; Liu S; Tong W; An B; Ding B; Ma P; Lin J
    Biomater Sci; 2023 Jun; 11(13):4549-4556. PubMed ID: 37159049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One Stone Two Birds: Zr-Fc Metal-Organic Framework Nanosheet for Synergistic Photothermal and Chemodynamic Cancer Therapy.
    Deng Z; Fang C; Ma X; Li X; Zeng YJ; Peng X
    ACS Appl Mater Interfaces; 2020 May; 12(18):20321-20330. PubMed ID: 32293862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MnO
    Li B; Wang X; Hong S; Wang Q; Li L; Eltayeb O; Dong C; Shuang S
    Food Funct; 2021 Jul; 12(14):6334-6347. PubMed ID: 34100053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemoglobin Nanocrystals for Drugs Free, Synergistic Theranostics of Colon Tumor.
    Zhou R; Xu H; Qu J; Ohulchanskyy TY
    Small; 2023 Feb; 19(8):e2205165. PubMed ID: 36508710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of iron-mineralized black phosphorene nanosheet to combinate chemodynamic therapy and photothermal therapy.
    Shi Z; Tang J; Lin C; Chen T; Zhang F; Huang Y; Luan P; Xin Z; Li Q; Mei L
    Drug Deliv; 2022 Dec; 29(1):624-636. PubMed ID: 35174748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.